Arecor Therapeutics plc (AIM:AREC)
London
· Delayed Price · Currency is GBP · Price in GBX 63.11
-2.89 (-4.38%)
Apr 29, 2026, 9:15 AM GMT
Arecor Therapeutics Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 3 | 3.24 | 5.09 | 4.77 | 18.32 | Upgrade
|
| Short-Term Investments | 3.13 | 0.02 | 1.66 | 8.04 | - | Upgrade
|
| Cash & Short-Term Investments | 6.13 | 3.26 | 6.75 | 12.81 | 18.32 | Upgrade
|
| Cash Growth | 88.21% | -51.76% | -47.27% | -30.08% | 532.02% | Upgrade
|
| Accounts Receivable | 0.63 | 2.53 | 2.27 | 0.66 | 0.71 | Upgrade
|
| Other Receivables | 0.24 | 1 | 1.06 | 2.16 | 0.86 | Upgrade
|
| Receivables | 0.87 | 3.53 | 3.32 | 2.82 | 1.57 | Upgrade
|
| Inventory | - | 0.48 | 0.77 | 1.13 | - | Upgrade
|
| Prepaid Expenses | - | 0.97 | 0.32 | 0.72 | 0.63 | Upgrade
|
| Other Current Assets | 0.7 | - | - | - | - | Upgrade
|
| Total Current Assets | 7.7 | 8.23 | 11.17 | 17.48 | 20.52 | Upgrade
|
| Property, Plant & Equipment | 0.3 | 0.4 | 0.83 | 0.84 | 0.33 | Upgrade
|
| Goodwill | - | - | 1.48 | 1.48 | - | Upgrade
|
| Other Intangible Assets | 0.02 | 0.03 | 1.81 | 1.92 | 0.03 | Upgrade
|
| Other Long-Term Assets | 0.09 | 0.06 | 0.08 | 0.05 | 0.05 | Upgrade
|
| Total Assets | 8.1 | 8.72 | 15.38 | 21.77 | 20.92 | Upgrade
|
| Accounts Payable | 1.42 | 1.02 | 2.25 | 1.71 | 0.52 | Upgrade
|
| Accrued Expenses | - | 1.78 | 2.13 | 1.27 | 1.17 | Upgrade
|
| Current Portion of Leases | 0.1 | 0.12 | 0.12 | 0.2 | 0.13 | Upgrade
|
| Current Income Taxes Payable | - | 0.09 | 0.1 | 0.12 | 0.09 | Upgrade
|
| Current Unearned Revenue | - | 0.09 | 0.23 | 0.21 | 0.35 | Upgrade
|
| Other Current Liabilities | 0.1 | 0.16 | 0.32 | 0.22 | 0.02 | Upgrade
|
| Total Current Liabilities | 1.61 | 3.26 | 5.15 | 3.73 | 2.27 | Upgrade
|
| Long-Term Leases | 0 | 0.11 | 0.22 | 0.09 | 0.11 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | 0.45 | 0.5 | - | Upgrade
|
| Other Long-Term Liabilities | 0.04 | 0.01 | 0.03 | - | - | Upgrade
|
| Total Liabilities | 1.65 | 3.37 | 5.85 | 4.31 | 2.37 | Upgrade
|
| Common Stock | 0.38 | 0.38 | 0.31 | 0.31 | 0.28 | Upgrade
|
| Additional Paid-In Capital | 34.68 | 34.68 | 28.98 | 28.98 | 23.35 | Upgrade
|
| Retained Earnings | -44.29 | -44.96 | -34.72 | -26.18 | -17.05 | Upgrade
|
| Comprehensive Income & Other | 15.69 | 15.25 | 14.97 | 14.35 | 11.97 | Upgrade
|
| Shareholders' Equity | 6.45 | 5.35 | 9.53 | 17.46 | 18.55 | Upgrade
|
| Total Liabilities & Equity | 8.1 | 8.72 | 15.38 | 21.77 | 20.92 | Upgrade
|
| Total Debt | 0.1 | 0.23 | 0.34 | 0.29 | 0.23 | Upgrade
|
| Net Cash (Debt) | 6.03 | 3.03 | 6.41 | 12.52 | 18.09 | Upgrade
|
| Net Cash Growth | 99.41% | -52.84% | -48.76% | -30.78% | 1902.77% | Upgrade
|
| Net Cash Per Share | 0.15 | 0.09 | 0.21 | 0.43 | 0.79 | Upgrade
|
| Filing Date Shares Outstanding | 37.76 | 37.76 | 30.63 | 30.62 | 27.84 | Upgrade
|
| Total Common Shares Outstanding | 37.76 | 37.76 | 30.63 | 30.62 | 27.84 | Upgrade
|
| Working Capital | 6.09 | 4.98 | 6.02 | 13.75 | 18.25 | Upgrade
|
| Book Value Per Share | 0.17 | 0.14 | 0.31 | 0.57 | 0.67 | Upgrade
|
| Tangible Book Value | 6.44 | 5.32 | 6.23 | 14.05 | 18.52 | Upgrade
|
| Tangible Book Value Per Share | 0.17 | 0.14 | 0.20 | 0.46 | 0.67 | Upgrade
|
| Machinery | - | 1.44 | 1.18 | 1.17 | 0.76 | Upgrade
|
| Leasehold Improvements | - | 0.16 | 0.14 | 0.1 | 0.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.